Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MLABthis companyMesa Laboratories, Inc.	$131.87	72.48×	2.62×	1.96×	17.84×	-93.2%	63.5%	7.4%	2.7%	3.6%	2.8%	8.1%	0.91×	4.02×	1.73×	1.72×	0.7%	7	2.05	2	B-
AAgilent Technologies, Inc.	$176.74	31.89×	6.14×	5.96×	23.43×	-60.2%	52.4%	21.3%	18.8%	19.3%	12.6%	2.8%	0.5×	0.85×	13.21×	1.96×	0.7%	6	5.82	3	B+
BIOBio-Rad Laboratories, Inc.	$386.07	10.87×	1.11×	3.2×	7.65×	-146.4%	52.0%	10.5%	29.4%	10.2%	2.0%	4.5%	0.21×	0.83×	5.52×	5.62×	0.0%	7	3.65	3	B
LABStandard BioTools Inc.	$0.65	-6.4×	1.15×	5.72×	-4.68×	-325.1%	49.9%	-109.3%	-87.8%	-17.7%	-12.2%	-16.9%	0.07×	1.02×	-3,588.65×	4.19×	0.0%	3	-0.44	2	C+
MRVIMaravai LifeSciences Holdings, Inc.	$8.00	-3.57×	2.22×	2.54×	-4.86×	-66.3%	18.0%	-3.6%	-70.4%	-61.6%	-0.9%	-15.0%	0.17×	1.23×	-0.25×	6.6×	0.0%	4	4.88	1	C-
PACBPacific Biosciences of California, Inc.	$2.26	-1.03×	104.87×	3.51×	-8.23×	-472.5%	31.7%	-348.5%	-341.5%	-10214.5%	-76.4%	-20.3%	142.07×	-4.56×	-80.18×	6.89×	0.0%	2	-4.47	2	B-
Peer median	—	-1.03×	2.22×	3.51×	-4.68×	-146.4%	49.9%	-3.6%	-70.4%	-17.7%	-0.9%	-15.0%	0.21×	0.85×	-0.25×	5.62×	0.0%	4	3.65	2	—